Evidence map›Paper›PMID 33916755›Full record

ArticleMolecules (Basel, Switzerland)2021

Modular Synthetic Approach to Carboranyl‒Biomolecules Conjugates.

Martin Kellert, Jan-Simon Jeshua Friedrichs, Nadine Anke Ullrich, Alexander Feinhals, Jonas Tepper, Peter Lönnecke, Evamarie Hey-Hawkins

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. New Boron Delivery Agents.Cancer biotherapy & radiopharmaceuticals · 2023
    Review
  3. Carborane-Containing Folic AcidInternational journal of molecular sciences · 2022
    Article
  4. Tumor Cell-Specific 2'-Fluoro RNA Aptamer Conjugated withInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Martin KellertInstitute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, 04103 Leipzig, Germany.ORCID 0000-0003-4334-1836
Jan-Simon Jeshua FriedrichsInstitute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, 04103 Leipzig, Germany.
Nadine Anke UllrichInstitute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, 04103 Leipzig, Germany.
Alexander FeinhalsInstitute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, 04103 Leipzig, Germany.ORCID 0000-0003-2102-8304
Jonas TepperInstitute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, 04103 Leipzig, Germany.
Peter LönneckeInstitute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, 04103 Leipzig, Germany.
Evamarie Hey-HawkinsInstitute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, Johannisallee 29, 04103 Leipzig, Germany.ORCID 0000-0003-4267-0603
Leipzig University · DE

Funding

European Regional Development Fund EHHEuropean Social Fund EHHGraduate School BuildMoNa LU
6 · The paper itself

Abstract

The development of novel, tumor-selective and boron-rich compounds as potential agents for use in boron neutron capture therapy (BNCT) represents a very important field in cancer treatment by radiation therapy. Here, we report the design and synthesis of two promising compounds that combine

Indexed as

AminesBoron CompoundsCarboxylic AcidsCoumarinsFolic AcidGlycine7-amino-4-methylcoumarinAminesBoron CompoundsCarboxylic AcidsCoumarinsFolic AcidGlycineboron neutron cancer therapy (BNCT)carboxylic acids and aminesmodular approach

Identifiers

PMID33916755
PMCPMC8038343
OpenAlexW3148542788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.